LMNL
Price:
$8.5
Market Cap:
$38.61M
Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm, primarily engaged in creating innovative small molecule drug therapies. The company concentrates on addressing inflammatory, fibrotic, and metabolic diseases, with its operations spanning Canada and the United Kingdom. Its flagship drug candidate, fezagepras (identified as PBI-4050), has successfully advanced through Phase I clinical trials. This agent, along with its related derivatives, is undergoing investigation for potential application in treating idiopathic fibrosis affecting the lungs, liver, heart, or skin, as well as various respiratory conditions. Furthermore, Liminal is advancing antagonist programs, in...[Read more]
Industry
Biotechnology
IPO Date
2009-12-18
Stock Exchange
NASDAQ
Ticker
LMNL
According to Liminal BioSciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.09. This represents a change of 5.78% compared to the average of 3.87 of the last 4 quarters.
The mean historical Current Ratio of Liminal BioSciences Inc. over the last ten years is 2.74. The current 4.09 Current Ratio has changed 14.84% with respect to the historical average. Over the past ten years (40 quarters), LMNL's Current Ratio was at its highest in in the June 2016 quarter at 6.65. The Current Ratio was at its lowest in in the June 2014 quarter at 0.52.
Average
2.74
Median
2.52
Minimum
1.14
Maximum
6.20
Discovering the peaks and valleys of Liminal BioSciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 186.67%
Maximum Annual Current Ratio = 6.20
Minimum Annual Increase = -43.03%
Minimum Annual Current Ratio = 1.14
| Year | Current Ratio | Change |
|---|---|---|
| 2022 | 4.09 | -34.02% |
| 2021 | 6.20 | 101.86% |
| 2020 | 3.07 | 1.20% |
| 2019 | 3.03 | 165.42% |
| 2018 | 1.14 | -43.03% |
| 2017 | 2.01 | 0.10% |
| 2016 | 2.00 | -38.65% |
| 2015 | 3.27 | 186.67% |
| 2014 | 1.14 | -20.20% |
| 2013 | 1.43 | 7.80% |
The current Current Ratio of Liminal BioSciences Inc. (LMNL) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.45
5-year avg
3.51
10-year avg
2.74
Liminal BioSciences Inc.’s Current Ratio is greater than Freeline Therapeutics Holdings plc (2.18), less than Serina Therapeutics, Inc. (4.18), greater than AnPac Bio-Medical Science Co., Ltd. (0.32), greater than LakeShore Biopharma Co., Ltd (1.02), less than Allakos Inc. (14.23), greater than Angion Biomedica Corp. (2.24), greater than Marinus Pharmaceuticals, Inc. (4.07), greater than Vincerx Pharma, Inc. (1.79), less than Opus Genetics, Inc. (7.13), greater than Traws Pharma, Inc. (0.43),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.18 | $28.28M | |
| 4.18 | $19.93M | |
| 0.32 | $26.97M | |
| 1.02 | $25.84M | |
| 14.23 | $29.74M | |
| 2.24 | $30.11M | |
| 4.07 | $30.37M | |
| 1.79 | $68.57K | |
| 7.13 | $328.84M | |
| 0.43 | $11.70M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Liminal BioSciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Liminal BioSciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Liminal BioSciences Inc.'s Current Ratio?
How is the Current Ratio calculated for Liminal BioSciences Inc. (LMNL)?
What is the highest Current Ratio for Liminal BioSciences Inc. (LMNL)?
What is the 3-year average Current Ratio for Liminal BioSciences Inc. (LMNL)?
What is the 5-year average Current Ratio for Liminal BioSciences Inc. (LMNL)?
How does the current Current Ratio for Liminal BioSciences Inc. (LMNL) compare to its historical average?